Europe PMC
Verdict: MajorRetatrutide Once Weekly for Treatment of Obstructive Sleep Apnea
Retatrutide, an investigational triple agonist of glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors, may be useful for treating obstructive sleep apnea (OSA).